Xelox
[(1R,2R)-2-azanidylcyclohexyl]azanide;oxalate;pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate;platinum(4+)
Molecular Identity
Xelox
[(1R,2R)-2-azanidylcyclohexyl]azanide;oxalate;pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate;platinum(4+)
PubChem CID: 71301229
2D Structure
Properties
C23H34FN5O10Pt
Molecular Formula
754.60
Molecular Weight
g/mol
754.1938
Exact Mass
Da
203
TPSA
May have limited oral absorption
5
H-Bond Donors
13
H-Bond Acceptors
772
Complexity
SMILES
Canonical SMILES
SMILES: CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O.C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)[O-])[O-].[Pt+4]Isomeric SMILES
SMILES: CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O.C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)[O-])[O-].[Pt+4]Synonyms(7)
XELOXXelox RTEloxatin / xelodaCapecitabine and OxaliplatinCapeOxOxaliplatin regimen with CapecitabineCytidine, 5'-deoxy-5-fluoro-N-((pentyloxy)carbonyl)-, mixt. with (SP-4-2)-((1R,2R)-1,2-cyclohexanediamine-kappaN1,kappaN2)(ethanedioato(2-)-kappaO1,kappaO2)platinum
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Xelox
Loading drug network...